drugset / Trial / NCT00249119
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to evaluate the effectiveness and safety of different doses of risperidone (an antipsychotic medication) compared with a fixed 10-mg dose of a standard antipsychotic, haloperidol, in patients with chronic schizophrenia.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 1991-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risperidone | Other / unclassified | 0.5 mg | Oral |
| Subject | Risperidone | Other / unclassified | 2 mg | Oral |
| Subject | Risperidone | Other / unclassified | 4 mg | Oral |
| Subject | Risperidone | Other / unclassified | 6 mg | Oral |
| Subject | Risperidone | Other / unclassified | 8 mg | Oral |